DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ advanced 1.49% to $756.91 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 1.01% to 6,699.38 and the Dow Jones Industrial Average rising 0.83% to 46,946.41.
The stock's rise snapped a two-day losing streak.
Regeneron Pharmaceuticals Inc. closed 7.82% below its 52-week high of $821.11, which the company reached on January 9th.
The stock outperformed some of its competitors Monday, as Amgen Inc. $(AMGN)$ rose 0.01% to $366.25, Moderna Inc. (MRNA) rose 1.43% to $53.31, and Gilead Sciences Inc. (GILD) rose 0.15% to $145.21.
Trading volume (395,538) remained 385,301 below its 50-day average volume of 780,839.
Data source: Dow Jones Market Data, FactSet. Data compiled March 16, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 16, 2026 16:42 ET (20:42 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments